Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has reported Other Non-Current Liabilities for 6 consecutive years, with $16.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 139.82% year-over-year to $16.7 million; the TTM figure through Dec 2025 stood at $16.7 million (up 139.82% YoY), while the FY2025 annual figure was $16.7 million, up 139.82% from the prior year.
• Other Non-Current Liabilities came in at $16.7 million for Q4 2025 at Cellebrite DI, up from $7.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $54.1 million in Q4 2023, with the low at $5.0 million in Q2 2023.
• Average Other Non-Current Liabilities over 5 years is $9.8 million, with a median of $6.6 million recorded in 2022.
• Across the five-year window, Other Non-Current Liabilities surged 903.28% in 2023 and tumbled 87.15% in 2024, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $9.5 million in 2021, then sank by 43.44% to $5.4 million in 2022, then soared by 903.28% to $54.1 million in 2023, then sank by 87.15% to $7.0 million in 2024, then surged by 139.82% to $16.7 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $16.7 million, $7.5 million, and $6.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.